Oxytocin and Vasopressin Agonists and Antagonists as Research Tools and Potential TherapeuticsM. Manning, Gilles Guillon, Maïthé Corbani et al.|Journal of Neuroendocrinology|2012Cited by 424
Peptide and non-peptide agonists and antagonists for the vasopressin and oxytocin V1a, V1b, V2 and OT receptors: research tools and potential therapeutic agents☆M. Manning, Gilles Guillon, Bernard Mouillac et al.|Progress in brain research|2008Cited by 289
The Binding Site of Neuropeptide Vasopressin V1a ReceptorBernard Mouillac, Claude Barberis, Marie‐Noëlle Balestre et al.|Journal of Biological Chemistry|1995Cited by 266
Tyr115 is the key residue for determining agonist selectivity in the V1a vasopressin receptor.Bice Chini, Serge Jard, Bernard Mouillac et al.|The EMBO Journal|1995Cited by 181
Two aromatic residues regulate the response of the human oxytocin receptor to the partial agonist arginine vasopressinBice Chini, Claude Barberis, Bernard Mouillac et al.|FEBS Letters|1996Cited by 111